Sign Up to like & get
recommendations!
2
Published in 2022 at "Journal of agricultural and food chemistry"
DOI: 10.1021/acs.jafc.1c07241
Abstract: Tangeretin (TAN) exhibits many bioactivities, including neuroprotective effects. However, the efficacy of TAN in Alzheimer's disease (AD) has not been sufficiently investigated. In the present study, we integrated behavioral tests, pathology assessment, and biochemical analyses…
read more here.
Keywords:
activity attenuates;
inhibits bace1;
pathology;
activity ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Journal of Alzheimer's Disease"
DOI: 10.3233/jad-215542
Abstract: Background: Beta-site APP cleaving enzyme 1 (BACE1) is the rate-limiting enzyme in amyloid-β (Aβ) plaques formation. BACE1 activity is increased in brains of patients with Alzheimer’s disease (AD) and mild cognitive impairment (MCI) and plasma…
read more here.
Keywords:
alzheimer disease;
activity;
bace1 activity;
activity early ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Pharmaceuticals"
DOI: 10.3390/ph14090901
Abstract: Alzheimer’s disease (AD) is implicated in the imbalance of several proteins, including Amyloid-β (Aβ), amyloid precursor protein (APP), and BACE1. APP overexpression interferes with neurite outgrowth, while BACE1 plays a role in Aβ generation. Medicinal…
read more here.
Keywords:
bace1 activity;
neurite outgrowth;
app overexpressing;
outgrowth ... See more keywords